CAV1 and non-small cell lung carcinoma: Recent studies have demonstrated that Cav-1 can directly confer the anoikis resistance in NSCLC by the interaction with its antiapoptotic partner Mcl-1 protein and prevent the latter protein from the degradation by the ubiquitin-proteasomal system [17].